Principal Investigator
Roy Levitt
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20210975
Clinical Trial Summary
A PHASE 2, RANDOMIZED, ACTIVE AND PLACEBO-CONTROLLED, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF INTRA-ARTICULAR RESINIFERATOXIN TO TREAT MODERATE TO SEVERE PAIN FROM KNEE OSTEOARTHRITIS
Phase
Phase II
Funding Agency/Sponsor
Disease
Other
Contact Information
Phone Number
+1 (786) 3568078